Medicare's New $50 GLP-1 Copay Is Temporary and Expires in 2027 — Millions of Seniors Could Lose Access Again

The Medicare GLP-1 Bridge program launched on July 1, 2026, giving eligible Medicare Part D enrollees access to Wegovy, Zepbound, and the new oral GLP-1 pill Foundayo at a fixed $50 monthly copay. The program expires December 31, 2027. BALANCE program is delayed with no permanent coverage framework established. Millions of seniors face potential loss of access to these medications after the bridge program ends.